-
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Real-World Adherence, Healthcare Resource Utilization, And Costs Among Patients With Schizophrenia Utilizing Once-Monthly, Once-Every-Three-Months, And Once-Every-Six-Months Paliperidone Palmitate in the United States
Mar 10, 2025, 14:00 PM -
Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Economic Burden of HER2+ Breast Cancer and the Targeted Therapies Epidemiological & Economic Impact in Trinidad and Tobago
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Polygenic Risk Score-Guided Breast Cancer Screening Using a Discrete Event Simulation Model
Mar 10, 2025, 14:00 PM -
Clinical Outcomes and Healthcare Resource Utilization in Moderate to Late Preterm Infants With Respiratory Distress Syndrome
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases
Mar 10, 2025, 14:00 PM -
A Simple and Practical Guide to Implementing Generalized Risk-Adjusted Cost-Effectiveness (GRACE): A Case Study in Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Impact Analysis of Statin Discontinuation on Healthcare Resource Utilization (HCRU) and Cost of Care in Patients With Atherosclerotic Cardiovascular Disease (ASCVD) in the US
Mar 10, 2025, 14:00 PM -
Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention
Mar 10, 2025, 14:00 PM -
Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database
Mar 10, 2025, 14:00 PM -
Canada’s Evolving Market for Biosimilars and What It Means for Payers
Mar 10, 2025, 14:00 PM -
Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer
Mar 10, 2025, 14:00 PM -
Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
Mar 10, 2025, 14:00 PM -
Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data
Mar 10, 2025, 14:00 PM -
Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023
Mar 10, 2025, 14:00 PM -
Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey
Mar 10, 2025, 14:00 PM
